Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Evaluating NeuroVision's Neural Vision Correction (NVC) Myopia Treatment
Evaluating the Efficacy of NeuroVisions's NVC Treatment for Low Myopia
Status: Enrolling
Updated:  12/31/1969
College of Optometry, The Ohio State University
mi
from
Columbus, OH
Evaluating NeuroVision's Neural Vision Correction (NVC) Myopia Treatment
Evaluating the Efficacy of NeuroVisions's NVC Treatment for Low Myopia
Status: Enrolling
Updated: 12/31/1969
College of Optometry, The Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Sacramento, CA
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Golden, CO
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Golden, CO
Click here to add this to my saved trials
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Oak Park, IL
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oak Park, IL
Click here to add this to my saved trials
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Jackson, MI
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jackson, MI
Click here to add this to my saved trials
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
New Brunswick, NJ
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Palisades Park, NJ
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Palisades Park, NJ
Click here to add this to my saved trials
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
New York, NY
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Orchard Park, NY
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Orchard Park, NY
Click here to add this to my saved trials
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Austin, TX
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated:  12/31/1969
509
mi
from
Graz,
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Status: Enrolling
Updated: 12/31/1969
509
mi
from
Graz,
Click here to add this to my saved trials
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Status: Enrolling
Updated:  12/31/1969
Texan Allergy & Sinus Center
mi
from
Austin, TX
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Status: Enrolling
Updated: 12/31/1969
Texan Allergy & Sinus Center
mi
from
Austin, TX
Click here to add this to my saved trials
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Status: Enrolling
Updated:  12/31/1969
Texan Allergy & Sinus Center
mi
from
Grapevine, TX
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Status: Enrolling
Updated: 12/31/1969
Texan Allergy & Sinus Center
mi
from
Grapevine, TX
Click here to add this to my saved trials
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Status: Enrolling
Updated:  12/31/1969
Texan Allergy & Sinus Center
mi
from
San Antonio, TX
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study
Status: Enrolling
Updated: 12/31/1969
Texan Allergy & Sinus Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy Study of Ketorolac and HPMC to Treat Dry Eye
A Double-Masked, Randomized, Single-Center Study Evaluating the Effect of 0.30% Ketorolac/0.80% HPMC, 0.80% HPMC and Vehicle on Symptoms of Dry Eye After Exposure to the Controlled Adverse Environment (CAE)
Status: Enrolling
Updated:  12/31/1969
Ophthalmic Reserach Associates
mi
from
Andover, MA
Efficacy Study of Ketorolac and HPMC to Treat Dry Eye
A Double-Masked, Randomized, Single-Center Study Evaluating the Effect of 0.30% Ketorolac/0.80% HPMC, 0.80% HPMC and Vehicle on Symptoms of Dry Eye After Exposure to the Controlled Adverse Environment (CAE)
Status: Enrolling
Updated: 12/31/1969
Ophthalmic Reserach Associates
mi
from
Andover, MA
Click here to add this to my saved trials
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated:  12/31/1969
EyeCenter Optometrics
mi
from
Rocklin, CA
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated: 12/31/1969
EyeCenter Optometrics
mi
from
Rocklin, CA
Click here to add this to my saved trials
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated:  12/31/1969
Fleming Island Vision Center
mi
from
Fleming Island, FL
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated: 12/31/1969
Fleming Island Vision Center
mi
from
Fleming Island, FL
Click here to add this to my saved trials
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated:  12/31/1969
Bartram Eye Clinic
mi
from
Jacksonville, FL
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated: 12/31/1969
Bartram Eye Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated:  12/31/1969
Sabal Eye Care
mi
from
Longwood, FL
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated: 12/31/1969
Sabal Eye Care
mi
from
Longwood, FL
Click here to add this to my saved trials
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated:  12/31/1969
Maitland Vision Center
mi
from
Maitland, FL
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated: 12/31/1969
Maitland Vision Center
mi
from
Maitland, FL
Click here to add this to my saved trials
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated:  12/31/1969
St. Johns Eye Associates
mi
from
Saint Augustine, FL
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated: 12/31/1969
St. Johns Eye Associates
mi
from
Saint Augustine, FL
Click here to add this to my saved trials
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated:  12/31/1969
Sacco Eye Group
mi
from
Vestal, NY
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated: 12/31/1969
Sacco Eye Group
mi
from
Vestal, NY
Click here to add this to my saved trials
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated:  12/31/1969
ProCare Vision Centers
mi
from
Granville, OH
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated: 12/31/1969
ProCare Vision Centers
mi
from
Granville, OH
Click here to add this to my saved trials
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated:  12/31/1969
EyeCare Professionals of Powell
mi
from
Powell, OH
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated: 12/31/1969
EyeCare Professionals of Powell
mi
from
Powell, OH
Click here to add this to my saved trials
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated:  12/31/1969
Primary Eyecare Group
mi
from
Brentwood, TN
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated: 12/31/1969
Primary Eyecare Group
mi
from
Brentwood, TN
Click here to add this to my saved trials
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated:  12/31/1969
Total Eye Care, PA
mi
from
Memphis, TN
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated: 12/31/1969
Total Eye Care, PA
mi
from
Memphis, TN
Click here to add this to my saved trials
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated:  12/31/1969
Boutetourt Eyecare, LLC
mi
from
Salem, VA
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Status: Enrolling
Updated: 12/31/1969
Boutetourt Eyecare, LLC
mi
from
Salem, VA
Click here to add this to my saved trials
Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model
A Phase 4, Randomized, Double-Masked, Single Center, Placebo-Controlled Adaptive Clinical Trial, Using Prednisolone Sodium Phosphate Ophthalmic Solution, 1%, in Subjects With Allergic Conjunctivitis to Evaluate a Modified Conjunctival Allergen Challenge (CAC) Model
Status: Enrolling
Updated:  12/31/1969
Andover Eye Associates
mi
from
Andover, MA
Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model
A Phase 4, Randomized, Double-Masked, Single Center, Placebo-Controlled Adaptive Clinical Trial, Using Prednisolone Sodium Phosphate Ophthalmic Solution, 1%, in Subjects With Allergic Conjunctivitis to Evaluate a Modified Conjunctival Allergen Challenge (CAC) Model
Status: Enrolling
Updated: 12/31/1969
Andover Eye Associates
mi
from
Andover, MA
Click here to add this to my saved trials
Intra-surgical Evaluation of CATS Tonometer Prism and Abbott Medical Optics Versus Alcon Phacoemulsification Machines
Intra-surgical Evaluation of CATS Tonometer Prism and AMO Versus Alcon Phacoemulsification Machines
Status: Enrolling
Updated:  12/31/1969
Arizona Eye Consultants
mi
from
Tucson, AZ
Intra-surgical Evaluation of CATS Tonometer Prism and Abbott Medical Optics Versus Alcon Phacoemulsification Machines
Intra-surgical Evaluation of CATS Tonometer Prism and AMO Versus Alcon Phacoemulsification Machines
Status: Enrolling
Updated: 12/31/1969
Arizona Eye Consultants
mi
from
Tucson, AZ
Click here to add this to my saved trials
Evaluation of Visual Performance With Contact Lenses
Evaluation of Visual Performance With Contact Lenses
Status: Enrolling
Updated:  12/31/1969
University of Houston
mi
from
Houston, TX
Evaluation of Visual Performance With Contact Lenses
Evaluation of Visual Performance With Contact Lenses
Status: Enrolling
Updated: 12/31/1969
University of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Design Validation of Senofilcon A With New UV-blocking Additive
Design Validation of Senofilcon A With New UV-blocking Additive
Status: Enrolling
Updated:  12/31/1969
James T. Fujimoto, OD
mi
from
Cupertino, CA
Design Validation of Senofilcon A With New UV-blocking Additive
Design Validation of Senofilcon A With New UV-blocking Additive
Status: Enrolling
Updated: 12/31/1969
James T. Fujimoto, OD
mi
from
Cupertino, CA
Click here to add this to my saved trials
Design Validation of Senofilcon A With New UV-blocking Additive
Design Validation of Senofilcon A With New UV-blocking Additive
Status: Enrolling
Updated:  12/31/1969
Maitland Vision Center
mi
from
Maitland, FL
Design Validation of Senofilcon A With New UV-blocking Additive
Design Validation of Senofilcon A With New UV-blocking Additive
Status: Enrolling
Updated: 12/31/1969
Maitland Vision Center
mi
from
Maitland, FL
Click here to add this to my saved trials
Design Validation of Senofilcon A With New UV-blocking Additive
Design Validation of Senofilcon A With New UV-blocking Additive
Status: Enrolling
Updated:  12/31/1969
Tallahassee Eye Center
mi
from
Tallahassee, FL
Design Validation of Senofilcon A With New UV-blocking Additive
Design Validation of Senofilcon A With New UV-blocking Additive
Status: Enrolling
Updated: 12/31/1969
Tallahassee Eye Center
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Design Validation of Senofilcon A With New UV-blocking Additive
Design Validation of Senofilcon A With New UV-blocking Additive
Status: Enrolling
Updated:  12/31/1969
Eyecare Associates LLP
mi
from
Bloomington, IL
Design Validation of Senofilcon A With New UV-blocking Additive
Design Validation of Senofilcon A With New UV-blocking Additive
Status: Enrolling
Updated: 12/31/1969
Eyecare Associates LLP
mi
from
Bloomington, IL
Click here to add this to my saved trials
Design Validation of Senofilcon A With New UV-blocking Additive
Design Validation of Senofilcon A With New UV-blocking Additive
Status: Enrolling
Updated:  12/31/1969
Kannarr Eye Care LLC
mi
from
Pittsburg, KA
Design Validation of Senofilcon A With New UV-blocking Additive
Design Validation of Senofilcon A With New UV-blocking Additive
Status: Enrolling
Updated: 12/31/1969
Kannarr Eye Care LLC
mi
from
Pittsburg, KA
Click here to add this to my saved trials
Design Validation of Senofilcon A With New UV-blocking Additive
Design Validation of Senofilcon A With New UV-blocking Additive
Status: Enrolling
Updated:  12/31/1969
ProCare Vision Centers
mi
from
Granville, OH
Design Validation of Senofilcon A With New UV-blocking Additive
Design Validation of Senofilcon A With New UV-blocking Additive
Status: Enrolling
Updated: 12/31/1969
ProCare Vision Centers
mi
from
Granville, OH
Click here to add this to my saved trials
Design Validation of Senofilcon A With New UV-blocking Additive
Design Validation of Senofilcon A With New UV-blocking Additive
Status: Enrolling
Updated:  12/31/1969
Professional Vision Care
mi
from
Westerville, OH
Design Validation of Senofilcon A With New UV-blocking Additive
Design Validation of Senofilcon A With New UV-blocking Additive
Status: Enrolling
Updated: 12/31/1969
Professional Vision Care
mi
from
Westerville, OH
Click here to add this to my saved trials
Design Validation of Senofilcon A With New UV-blocking Additive
Design Validation of Senofilcon A With New UV-blocking Additive
Status: Enrolling
Updated:  12/31/1969
Bradley Hines, OD
mi
from
Memphis, TN
Design Validation of Senofilcon A With New UV-blocking Additive
Design Validation of Senofilcon A With New UV-blocking Additive
Status: Enrolling
Updated: 12/31/1969
Bradley Hines, OD
mi
from
Memphis, TN
Click here to add this to my saved trials
Design Validation of Senofilcon A With New UV-blocking Additive
Design Validation of Senofilcon A With New UV-blocking Additive
Status: Enrolling
Updated:  12/31/1969
Frazier Vision, Inc.
mi
from
Tyler, TX
Design Validation of Senofilcon A With New UV-blocking Additive
Design Validation of Senofilcon A With New UV-blocking Additive
Status: Enrolling
Updated: 12/31/1969
Frazier Vision, Inc.
mi
from
Tyler, TX
Click here to add this to my saved trials
Design Validation of Senofilcon A With New UV-blocking Additive
Design Validation of Senofilcon A With New UV-blocking Additive
Status: Enrolling
Updated:  12/31/1969
Ziegler Leffingwell Eyecare
mi
from
New Berlin, WI
Design Validation of Senofilcon A With New UV-blocking Additive
Design Validation of Senofilcon A With New UV-blocking Additive
Status: Enrolling
Updated: 12/31/1969
Ziegler Leffingwell Eyecare
mi
from
New Berlin, WI
Click here to add this to my saved trials
A Study to Evaluate the Safety and Effectiveness of Restylane-Defyne for Punctual Occlusion
A Single-Arm, Single-Center, Randomized, Single-Masked Study to Evaluate Restylane Defyne for Canalicular Occlusion in Participants With Mild to Moderate Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
The Eye Care Institute
mi
from
Louisville, KY
A Study to Evaluate the Safety and Effectiveness of Restylane-Defyne for Punctual Occlusion
A Single-Arm, Single-Center, Randomized, Single-Masked Study to Evaluate Restylane Defyne for Canalicular Occlusion in Participants With Mild to Moderate Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
The Eye Care Institute
mi
from
Louisville, KY
Click here to add this to my saved trials
A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
A Long Term Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
A Long Term Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
A Long Term Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
John Hopkins University Hospital
mi
from
Baltimore, MD
A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
A Long Term Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
John Hopkins University Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
A Long Term Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
A Long Term Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Clinical Evaluation of Fitting Investigational Contact Lenses Phase 2
Clinical Evaluation of Fitting Investigational Contact Lenses Phase 2
Status: Enrolling
Updated:  12/31/1969
Vistakon Research Clinic
mi
from
Jacksonville, FL
Clinical Evaluation of Fitting Investigational Contact Lenses Phase 2
Clinical Evaluation of Fitting Investigational Contact Lenses Phase 2
Status: Enrolling
Updated: 12/31/1969
Vistakon Research Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Efficacy and Safety Study of IBI-10090 in Patients Undergoing Cataract Surgery
A Multicenter, Randomized, Double-masked, Dose-ranging, Phase 2 Study to Evaluate the Efficacy and Safety of IBI-10090 in Cataract Surgery Patients
Status: Enrolling
Updated:  12/31/1969
Altos Eye Physicians
mi
from
Los Altos, CA
Efficacy and Safety Study of IBI-10090 in Patients Undergoing Cataract Surgery
A Multicenter, Randomized, Double-masked, Dose-ranging, Phase 2 Study to Evaluate the Efficacy and Safety of IBI-10090 in Cataract Surgery Patients
Status: Enrolling
Updated: 12/31/1969
Altos Eye Physicians
mi
from
Los Altos, CA
Click here to add this to my saved trials